Stay updated on Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.

Latest updates to the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the government operating-status notice and the previous Revision: v3.4.1 banner.SummaryDifference0.5%

- Check21 days agoChange DetectedTwo additions include a government funding notice and a new revision label (Revision: v3.4.1), while the previous revision label (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedThe changes include a UI enhancement to show the glossary, capitalization adjustments in a QC-related label, and a version label update from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page; this appears to be an internal version update with no changes to study content or critical information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe updates are cosmetic/structural: they reorganize the Locations section and its entries (Val De Marne) and remove a footer link, without altering core trial information, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no visible changes to study details or page layout.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.